COVID-19 Update

Combatting Future Viral Threats with Vaccine Advances

The COVID-19 pandemic has led to many changes in how pharmaceutical companies develop vaccines.

What’s Next for COVID-19 Vaccines and Variants?

More technologies and treatments are emerging for COVID-19—along with new variants.

Key Elements for Assay Transfer Success

Partnerships formed during the COVID-19 pandemic have provided a platform for change in assay development and transfers.

Leader of the Pack?

September 02, 2020

AstraZeneca has potentially taken poll position in the race to develop a novel coronavirus vaccine, but will AZD1222 be ready in 2020?

Biopharma Gears Up Pandemic Response

September 02, 2020

Amid high expectations for a vaccine, bio/pharma readies capacity, weighs pressures.

Sanofi, Regeneron Halt Development of Kevzara as a Potential COVID-19 Treatment

September 02, 2020

The companies provided an update stating that the biologic did not meet a primary endpoint in a Phase III clinical trial when compared with placebo in the treatment of COVID-19 patients.

iBio and Planet Biotechnology Partner to Develop COVID-19 Therapeutic

September 02, 2020

The companies will collaborate on the production of a novel anti-SARS-CoV-2 immunoadhesin in iBio’s FastPharming manufacturing system.

EMA Evaluating COVID-19 Treatment

September 02, 2020

The agency is reviewing an application for Dexamethasone Taw for treating adult patients with COVID-19.

J&J to Supply the Government of Canada with Doses of its COVID-19 Vaccine Candidate

September 01, 2020

Negotiations for a final advance purchase agreement where the Government of Canada purchases the vaccine candidate on a not-for-profit basis for emergency pandemic use are underway.

Moderna in Discussions to Supply Japan with Doses of its COVID-19 Vaccine Candidate

September 01, 2020

The vaccine will be supplied by Moderna and distributed in Japan by Takeda Pharmaceutical starting in the first half of 2021 if the vaccine candidate receives regulatory approval.

Novavax to Supply Canada with Doses of its COVID-19 Vaccine Candidate

September 01, 2020

Novavax and the Government of Canada will finalize an advanced purchase agreement under which Novavax will supply doses of NVX-CoV2373 to Canada beginning in the second quarter of 2021.

Oxford Biomedica Collaborates with AstraZeneca for COVID-19 Vaccine Candidate Manufacturing

September 01, 2020

Oxford Biomedica will reserve capacity for AstraZeneca in three of its manufacturing suites in its new commercial manufacturing center, Oxbox, for 18 months.

Thermo Fisher Opens New Manufacturing Site for COVID-19 Sample Collection

August 31, 2020

The new facility, located in Lenexa, KS, will rapidly expand production of viral transport media.